Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

TLA Targeted Immuno Therapies AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 446 More Arrow 1,993 Less Arrow 1,817
Financial expenses 1,236 Less Arrow 816 Less Arrow 670
Earnings before taxes -10,773 More Arrow -9,198 More Arrow -6,342
EBITDA -6,300 More Arrow -5,761 More Arrow -4,902
Total assets 29,681 More Arrow 29,848 Less Arrow 29,668
Current assets 4,801 More Arrow 5,948 More Arrow 6,654
Current liabilities 39,588 Less Arrow 24,990 Less Arrow 16,385
Equity capital -22,162 More Arrow -11,390 More Arrow -2,191
- share capital 262 Equal arrow 262 Equal arrow 262
Employees (average) 4 Equal arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -74.7% More Arrow -38.2% More Arrow -7.4%
Turnover per employee 112 More Arrow 498 Less Arrow 454
Profit as a percentage of turnover -2415.5% More Arrow -461.5% More Arrow -349.0%
Return on assets (ROA) -32.1% More Arrow -28.1% More Arrow -19.1%
Current ratio 12.1% More Arrow 23.8% More Arrow 40.6%
Return on equity (ROE) 48.6% More Arrow 80.8% More Arrow 289.5%
Change turnover -1,547 More Arrow 176 Less Arrow -14,151
Change turnover % -78% More Arrow 10% Less Arrow -89%
Chg. No. of employees 0 Equal arrow 0 Less Arrow -2
Chg. No. of employees % 0% Equal arrow 0% Less Arrow -33%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.